General

How do severing enzymes strengthen and amplify microtubules? 5:02
How do severing enzymes strengthen and amplify microtubules?
Antonina Roll-Mecak • 5 May 2021
Using taxanes to counteract MT dysfunction induced by spastin loss 2:17
Using taxanes to counteract MT dysfunction induced by spastin loss
Antonina Roll-Mecak • 5 May 2021
Neuroimmunological adverse events associated with immune checkpoint inhibitors 4:05
Neuroimmunological adverse events associated with immune checkpoint inhibitors
Karin Woodman • 13 May 2021
Research needs to address neurologic complications of immune checkpoint inhibitor use 1:59
Research needs to address neurologic complications of immune checkpoint inhibitor use
Karin Woodman • 13 Apr 2021
What’s to come at AAN 2021? 1:00
What’s to come at AAN 2021?
Karin Woodman • 13 Apr 2021
Perspectives on therapies for disorders of consciousness 1:17
Perspectives on therapies for disorders of consciousness
Jan Claassen • 26 Apr 2021
The TRANSCENDS scholar program 2:38
The TRANSCENDS scholar program
Bruce Ovbiagele • 30 Apr 2021
Detecting and predicting recovery of consciousness 4:36
Detecting and predicting recovery of consciousness
Jan Claassen • 26 Apr 2021
Brain health equity 4:32
Brain health equity
Bruce Ovbiagele • 30 Apr 2021
Cytokine storm induced by SARS-CoV-2 infection 2:25
Cytokine storm induced by SARS-CoV-2 infection
Nizar Souayah • 13 Apr 2021
Diversification of the neurology workforce 4:53
Diversification of the neurology workforce
Bruce Ovbiagele • 30 Apr 2021
Strategies to achieve a diverse neurology workforce 3:03
Strategies to achieve a diverse neurology workforce
Bruce Ovbiagele • 30 Apr 2021
Clinical significance of white matter hyperintensities in mTBI 3:25
Clinical significance of white matter hyperintensities in mTBI
Jack Tsao • 27 Apr 2021
Unanswered questions in the field of TBI 2:04
Unanswered questions in the field of TBI
Jack Tsao • 27 Apr 2021
Neurological adverse events associated with immune checkpoint inhibitors 3:54
Neurological adverse events associated with immune checkpoint inhibitors
Takahisa Mikami • 26 Apr 2021
Perspectives on the the study of neurological adverse events caused by immune checkpoint inhibitors 3:19
Perspectives on the the study of neurological adverse events caused by immune checkpoint inhibitors
Takahisa Mikami • 26 Apr 2021
The content of VJNeurology is intended for healthcare professionals